AstraZeneca: Metreleptin receives mixed vote from FDA's panellists

BUY, Fair Value  3580p (+4%)

News published on December Thursday 12, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities